Target intelligence / Profile preview

Ankyrin repeat domain-containing protein 1 (ANKRD1)

Target
ANKRD1
Molecular classification
Transcription factor, Other (muscle ankyrin repeat protein family member)
01

Overview

Ankyrin repeat domain-containing protein 1 (ANKRD1 or Cardiac ankyrin repeat protein/CARP) is a cardiac- and skeletal muscle-enriched protein belonging to the muscle ankyrin repeat protein family[1][3][6]. It contains five tandem ankyrin repeats and plays key roles in transcriptional regulation, assembly of the sarcomere (the basic contractile unit of muscle), and mechanosensing of cardiac stress signals[1][3][6]. ANKRD1 acts as a nuclear transcription factor that negatively regulates cardiac gene expression, and is highly induced by cardiac stress and in various cardiomyopathies and heart failure states[1][3][5][6]. Its levels and activity are implicated in the pathogenesis of several heart and muscle diseases, and it is being explored as a sensitive and specific biomarker for certain cardiac and muscle diseases, as well as for predicting chemotherapy outcomes in ovarian cancer[3]. No direct modulating drugs are currently listed, and mechanisms of action for drug-target interactions are not established in available literature.

Other names
Cardiac ankyrin repeat proteinCARP
02

Biological functions

Transcriptional regulationSarcomere assemblyMechano-sensingCardiac stress response
03

Disease associations

Cardiovascular disease (e.g., heart failure)Cardiomyopathy (dilated and hypertrophic)Skeletal muscle myopathyOvarian adenocarcinomaMuscular dystrophyLupus nephritis
04

Biomarkers

Cardiac stress/heart failureRhabdomyosarcoma (differential diagnosis)Ovarian adenocarcinoma (chemotherapy response)Proteinuria severity in lupus nephritis

Beyond the preview

Go deeper on Ankyrin repeat domain-containing protein 1 (ANKRD1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat domain-containing protein 1 (ANKRD1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call